Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Oral Anticoagulant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02504177
What this trial is testing

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Yonsei University 433
Not applicableNot Yet RecruitingNCT06887270
What this trial is testing

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

Who this might be right for
Anticoagulant-induced BleedingDirect Oral AnticoagulantCancer+2 more
University Health Network, Toronto 10
Not applicableStudy completedNCT03477331
What this trial is testing

Antithrombotics' Therapeutic Optimization in Hospitalized Patients Using Physiologically- and Population-based Pharmacokinetic Modeling

Who this might be right for
Cardiovascular Diseases
University Hospital, Geneva 444
Not applicableLooking for participantsNCT07012291
What this trial is testing

Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™

Who this might be right for
Coagulation
Perosphere Technologies Inc. 150
Large-scale testing (Phase 3)Study completedNCT04662684
What this trial is testing

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

Who this might be right for
Covid19Venous Thromboembolism
Science Valley Research Institute 320
Not applicableStudy completedNCT04974684
What this trial is testing

DOT HeartMate 3 Study

Who this might be right for
LVAD (Left Ventricular Assist Device) Thrombosis
Institute for Clinical and Experimental Medicine 45
Large-scale testing (Phase 3)Study completedNCT02866838
What this trial is testing

Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

Who this might be right for
Intracerebral Hemorrhage
University Hospital, Basel, Switzerland 64
Large-scale testing (Phase 3)Study completedNCT02066454
What this trial is testing

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Who this might be right for
MyelomaVenous Thromboembolism
University Hospital, Grenoble 108
Large-scale testing (Phase 3)UnknownNCT03570281
What this trial is testing

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

Who this might be right for
Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
Samsung Medical Center 40
Post-approval studies (Phase 4)Study completedNCT07354230
What this trial is testing

Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs

Who this might be right for
Atrial Fibrillation (AF)
Pirogov Russian National Research Medical University 210
Not applicableNot Yet RecruitingNCT06884384
What this trial is testing

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

Who this might be right for
Antiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events
Central Hospital, Nancy, France 310
Not applicableLooking for participantsNCT07520890
What this trial is testing

Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)

Who this might be right for
Direct Oral Anticoagulants (DOACs)Oral Surgical Procedures
University of Pisa 100
Large-scale testing (Phase 3)Looking for participantsNCT06322953
What this trial is testing

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage

Who this might be right for
Traumatic Intracranial Haemorrhage
Walton Centre NHS Foundation Trust 1,084
Not applicableStudy completedNCT02643992
What this trial is testing

Per-procedural Concentration of Direct Oral Anticoagulants

Who this might be right for
Per-procedural Concentrations of Oral Anticoagulants
Fondation Ophtalmologique Adolphe de Rothschild 270
Not applicableStudy completedNCT05546957
What this trial is testing

Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

Who this might be right for
Healthy Volunteer
Regeneron Pharmaceuticals 60
Not applicableStudy completedNCT04192916
What this trial is testing

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 442
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Not applicableLooking for participantsNCT04660747
What this trial is testing

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,300
Not applicableUnknownNCT06171984
What this trial is testing

Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal

Who this might be right for
Thrombophilia
University Hospital, Strasbourg, France 200
Testing effectiveness (Phase 2)Study completedNCT04865978
What this trial is testing

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

Who this might be right for
Heart Failure
Palak Shah 30
Next Page